- インド
- バイアル
- バイオテック
- バーラト
- ワクチン
- 容器
- 新型コロナウイルス
- 令和
「インド医学研究評議会」の写真・グラフィックス・映像
- 提供元
- 日付
- 種類
- 向き
- カテゴリ
- 色
- 提供元
- 日付
- 24時間以内 0
- 48時間以内 0
- 72時間以内 0
- 7日以内 0
- 30日以内 0
- 1年以内 0
- 期間を指定 35
- 日付指定なし 35
- 種類
- 写真 30
- グラフィックス 0
- 映像 5
- 向き
- 縦 0
- 横 35
- 正方形 0
- カテゴリ
- ニュース
- スポーツ
- エンターテインメント
- 教育向け
- カテゴリ指定なし
- 色
- カラー 35
- モノクロ 0
- 古い順
- 1
- 古い順
2020年09月03日Serological survey testing for coronavirus in New Delhi, India - 03 Sep 2020September 3, 2020, New Delhi, India: A health worker collects a blood sample for use in the third round of serological survey testing for coronavirus at the Anganwadi Center..Health workers collects blood samples for Covid-19 antibody test during a serological survey at the Anganwadi Center near ITO in New Delhi. Serological survey conducted by ‘‘the Indian Council of Medical Research in collaboration with state health departments, National Centre for Disease Control and World Health Organization‘‘. The First Serological Survey conducted was in May 2020 and second was in July 2020. The first part of the survey aimed at detecting the number of people infected with COVID-19 in the general population, while the third round aimed at finding out the number of people infected with COVID-19 in containment zones of hotspots and in other areas in Delhi and 17,000 samples to be tested. (Credit Image: © Manish Rajput/SOPA Images via ZUMA Wire)、クレジット：©Ｍａｎｉｓｈ Ｒａｊｐｕｔ／ＳＯＰＡ Ｉｍａｇｅｓ ｖｉａ ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2020090701070
2020年09月03日Serological survey testing for coronavirus in New Delhi, India - 03 Sep 2020September 3, 2020, New Delhi, India: A health worker collects a blood sample for use in the third round of serological survey testing for coronavirus at the Anganwadi Center..Health workers collects blood samples for Covid-19 antibody test during a serological survey at the Anganwadi Center near ITO in New Delhi. Serological survey conducted by ‘‘the Indian Council of Medical Research in collaboration with state health departments, National Centre for Disease Control and World Health Organization‘‘. The First Serological Survey conducted was in May 2020 and second was in July 2020. The first part of the survey aimed at detecting the number of people infected with COVID-19 in the general population, while the third round aimed at finding out the number of people infected with COVID-19 in containment zones of hotspots and in other areas in Delhi and 17,000 samples to be tested. (Credit Image: © Manish Rajput/SOPA Images via ZUMA Wire)、クレジット：©Ｍａｎｉｓｈ Ｒａｊｐｕｔ／ＳＯＰＡ Ｉｍａｇｅｓ ｖｉａ ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2020090700908
2020年09月03日Serological survey testing for coronavirus in New Delhi, India - 03 Sep 2020September 3, 2020, New Delhi, India: A health worker collects a blood sample for use in the third round of serological survey testing for coronavirus at the Anganwadi Center..Health workers collects blood samples for Covid-19 antibody test during a serological survey at the Anganwadi Center near ITO in New Delhi. Serological survey conducted by ‘‘the Indian Council of Medical Research in collaboration with state health departments, National Centre for Disease Control and World Health Organization‘‘. The First Serological Survey conducted was in May 2020 and second was in July 2020. The first part of the survey aimed at detecting the number of people infected with COVID-19 in the general population, while the third round aimed at finding out the number of people infected with COVID-19 in containment zones of hotspots and in other areas in Delhi and 17,000 samples to be tested. (Credit Image: © Manish Rajput/SOPA Images via ZUMA Wire)、クレジット：©Ｍａｎｉｓｈ Ｒａｊｐｕｔ／ＳＯＰＡ Ｉｍａｇｅｓ ｖｉａ ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2020090701010
2020年09月03日Serological survey testing for coronavirus in New Delhi, India - 03 Sep 2020September 3, 2020, New Delhi, India: A health worker marks a test tube with blood samples for use in the third round of serological survey testing for coronavirus at the Anganwadi Center..Health workers collects blood samples for Covid-19 antibody test during a serological survey at the Anganwadi Center near ITO in New Delhi. Serological survey conducted by ‘‘the Indian Council of Medical Research in collaboration with state health departments, National Centre for Disease Control and World Health Organization‘‘. The First Serological Survey conducted was in May 2020 and second was in July 2020. The first part of the survey aimed at detecting the number of people infected with COVID-19 in the general population, while the third round aimed at finding out the number of people infected with COVID-19 in containment zones of hotspots and in other areas in Delhi and 17,000 samples to be tested. (Credit Image: © Manish Rajput/SOPA Images via ZUMA Wire)、クレジット：©Ｍａｎｉｓｈ Ｒａｊｐｕｔ／ＳＯＰＡ Ｉｍａｇｅｓ ｖｉａ ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2020090701024
2020年09月03日Serological survey testing for coronavirus in New Delhi, India - 03 Sep 2020September 3, 2020, New Delhi, India: A health worker collects a blood sample for use in the third round of serological survey testing for coronavirus at the Anganwadi Center..Health workers collects blood samples for Covid-19 antibody test during a serological survey at the Anganwadi Center near ITO in New Delhi. Serological survey conducted by ‘‘the Indian Council of Medical Research in collaboration with state health departments, National Centre for Disease Control and World Health Organization‘‘. The First Serological Survey conducted was in May 2020 and second was in July 2020. The first part of the survey aimed at detecting the number of people infected with COVID-19 in the general population, while the third round aimed at finding out the number of people infected with COVID-19 in containment zones of hotspots and in other areas in Delhi and 17,000 samples to be tested. (Credit Image: © Manish Rajput/SOPA Images via ZUMA Wire)、クレジット：©Ｍａｎｉｓｈ Ｒａｊｐｕｔ／ＳＯＰＡ Ｉｍａｇｅｓ ｖｉａ ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2020090700991
2020年10月21日Sex workers celebrates Durga Puja FestivalOctober 21, 2020, Kolkata, West Bengal, India: Indian sex workers gather to worship Hindu goddess Durga at a worship place set up at Sonagachhi, a red light district, in Kolkata, The five day Hindu festival Durga Puja began today October 22 and ends with immersion of idols. The Indian Council of Medical Research calls for sustained caution against COVID-19 and pointed out that any negligence could lead to reinfection. (Credit Image: © Dipa Chakraborty/Pacific Press via ZUMA Wire)、クレジット：©Ｄｉｐａ Ｃｈａｋｒａｂｏｒｔｙ／Ｐａｃｉｆｉｃ Ｐｒｅｓｓ ｖｉａ ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2020102206767
2020年10月21日Sex workers celebrates Durga Puja FestivalOctober 21, 2020, Kolkata, West Bengal, India: Indian sex workers put protective face mask on the Hindu Goddess Durga idol at a worship place set up by sex workers in Kolkata. The five day Hindu festival Durga Puja began today October 22 and ends with immersion of idols. The Indian Council of Medical Research calls for sustained caution against COVID-19 and pointed out that any negligence could lead to reinfection. (Credit Image: © Dipa Chakraborty/Pacific Press via ZUMA Wire)、クレジット：©Ｄｉｐａ Ｃｈａｋｒａｂｏｒｔｙ／Ｐａｃｉｆｉｃ Ｐｒｅｓｓ ｖｉａ ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2020102206892
2020年10月21日Sex workers celebrates Durga Puja FestivalOctober 21, 2020, Kolkata, West Bengal, India: Indian sex workers put protective face mask on the Hindu Goddess Durga idol at a worship place set up by sex workers in Kolkata. The five day Hindu festival Durga Puja began today October 22 and ends with immersion of idols. The Indian Council of Medical Research calls for sustained caution against COVID-19 and pointed out that any negligence could lead to reinfection. (Credit Image: © Dipa Chakraborty/Pacific Press via ZUMA Wire)、クレジット：©Ｄｉｐａ Ｃｈａｋｒａｂｏｒｔｙ／Ｐａｃｉｆｉｃ Ｐｒｅｓｓ ｖｉａ ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2020102206845
2020年10月21日Sex workers celebrates Durga Puja FestivalOctober 21, 2020, Kolkata, West Bengal, India: Indian sex workers put protective face mask on the Hindu Goddess Durga idol at a worship place set up by sex workers in Kolkata. The five day Hindu festival Durga Puja began today October 22 and ends with immersion of idols. The Indian Council of Medical Research calls for sustained caution against COVID-19 and pointed out that any negligence could lead to reinfection. (Credit Image: © Dipa Chakraborty/Pacific Press via ZUMA Wire)、クレジット：©Ｄｉｐａ Ｃｈａｋｒａｂｏｒｔｙ／Ｐａｃｉｆｉｃ Ｐｒｅｓｓ ｖｉａ ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2020102206961
2020年12月01日Launch of Phase 111 Regulatory Trial of COVAXI in Kolkata, India - 1 Dec 2020December 1, 2020, Kolkata, West Bengal, India: A woman wearing a facemask offers a bouquet of flowers to Governor, Jagdeep Dhankar during the inauguration ceremony..West Bengal Governor, Jagdeep Dhankar inaugurates the launch of Third phase trial of Covaxine at the Indian Council of Medical Research (ICMR) in Kolkata. (Credit Image: © Sumit Sanyal/SOPA Images via ZUMA Wire)、クレジット：©Ｓｕｍｉｔ Ｓａｎｙａｌ／ＳＯＰＡ Ｉｍａｇｅｓ ｖｉａ ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2020120305608
2020年12月01日Launch of Phase 111 Regulatory Trial of COVAXI in Kolkata, India - 1 Dec 2020December 1, 2020, Kolkata, West Bengal, India: A woman wearing a facemask offers a bouquet of flowers to Governor, Jagdeep Dhankar during the inauguration ceremony..West Bengal Governor, Jagdeep Dhankar inaugurates the launch of Third phase trial of Covaxine at the Indian Council of Medical Research (ICMR) in Kolkata. (Credit Image: © Sumit Sanyal/SOPA Images via ZUMA Wire)、クレジット：©Ｓｕｍｉｔ Ｓａｎｙａｌ／ＳＯＰＡ Ｉｍａｇｅｓ ｖｉａ ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2020120305470
2020年12月01日Launch of Phase 111 Regulatory Trial of COVAXI in Kolkata, India - 1 Dec 2020December 1, 2020, Kolkata, West Bengal, India: Governor, Jagdeep Dhankar wearing a facemask departs the Research center..West Bengal Governor, Jagdeep Dhankar inaugurates the launch of Third phase trial of Covaxine at the Indian Council of Medical Research (ICMR) in Kolkata. (Credit Image: © Sumit Sanyal/SOPA Images via ZUMA Wire)、クレジット：©Ｓｕｍｉｔ Ｓａｎｙａｌ／ＳＯＰＡ Ｉｍａｇｅｓ ｖｉａ ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2020120305553
2020年12月02日Launch of Phase 111 Regulatory Trial of COVAXI in Kolkata, India - 1 Dec 2020December 2, 2020, Kolkata, West Bengal, India: A banner reading ‘‘Launch of Phase 111 Regulatory Trial of COVAXI‘‘ is seen displayed at the Indian Council of Medical Research (ICMR)..West Bengal Governor, Jagdeep Dhankar inaugurates the launch of Third phase trial of Covaxine at the Indian Council of Medical Research (ICMR) in Kolkata. (Credit Image: © Sumit Sanyal/SOPA Images via ZUMA Wire)、クレジット：©Ｓｕｍｉｔ Ｓａｎｙａｌ／ＳＯＰＡ Ｉｍａｇｅｓ ｖｉａ ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2020120305342
2021年03月06日India‘s Covid NightmareMarch 6, 2021, Barpeta, Assam, India: A health worker wearing gloves shows a Bharat Biotech COVAXIN dose at a government hospital in Barpeta. India has entered the second phase of its vaccination drive with two ‘Made in India‘ vaccines Covishield and Covaxin. The Indian Council of Medical Research announced that phase 3 results of Covaxin have shown an interim vaccine efficacy of 81 percent in preventing COVID-19. (Credit Image: © David Talukdar/ZUMA Wire)、クレジット：©Ｄａｖｉｄ Ｔａｌｕｋｄａｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021063007628
2021年03月06日Coronavirus Vaccination in Indiaキーワード：新型コロナウイルス、ワクチン、バーラト・バイオテック、インド、実物、バイアル、容器、瓶－March 6, 2021, Barpeta, Assam, India: A health worker wearing gloves shows a Bharat Biotech COVAXIN dose at a government hospital on March 6, 2021 in Barpeta, India. India has entered the second phase of its vaccination drive with two ‘Made in India vaccines- Covishield and Covaxin. The Indian Council of Medical Research and Bharat Biotech announced that phase 3 results of Covaxin have shown an interim vaccine efficacy of 81 percent in preventing COVID-19. (Credit Image: © David Talukdar/ZUMA Wire)、クレジット：©Ｄａｖｉｄ Ｔａｌｕｋｄａｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021031109388
2021年03月06日Coronavirus Vaccination in Indiaキーワード：新型コロナウイルス、ワクチン、バーラト・バイオテック、インド、実物、バイアル、容器、瓶－March 6, 2021, Barpeta, Assam, India: A health worker wearing gloves shows a Bharat Biotech COVAXIN dose at a government hospital on March 6, 2021 in Barpeta, India. India has entered the second phase of its vaccination drive with two ‘Made in India vaccines- Covishield and Covaxin. The Indian Council of Medical Research and Bharat Biotech announced that phase 3 results of Covaxin have shown an interim vaccine efficacy of 81 percent in preventing COVID-19. (Credit Image: © David Talukdar/ZUMA Wire)、クレジット：©Ｄａｖｉｄ Ｔａｌｕｋｄａｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021031109391
2021年03月06日Coronavirus Vaccination in Indiaキーワード：新型コロナウイルス、ワクチン、バーラト・バイオテック、インド、実物、バイアル、容器、瓶－March 6, 2021, Barpeta, Assam, India: A Bharat Biotech COVAXIN dose at a government hospital on March 6, 2021 in Barpeta, India. India has entered the second phase of its vaccination drive with two ‘Made in India vaccines- Covishield and Covaxin. The Indian Council of Medical Research and Bharat Biotech announced that phase 3 results of Covaxin have shown an interim vaccine efficacy of 81 percent in preventing COVID-19. (Credit Image: © David Talukdar/ZUMA Wire)、クレジット：©Ｄａｖｉｄ Ｔａｌｕｋｄａｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021031109387
2021年03月06日Coronavirus Vaccination in Indiaキーワード：新型コロナウイルス、ワクチン、バーラト・バイオテック、インド、実物、バイアル、容器、瓶－March 6, 2021, Barpeta, Assam, India: A Bharat Biotech COVAXIN dose at a government hospital on March 6, 2021 in Barpeta, India. India has entered the second phase of its vaccination drive with two ‘Made in India vaccines- Covishield and Covaxin. The Indian Council of Medical Research and Bharat Biotech announced that phase 3 results of Covaxin have shown an interim vaccine efficacy of 81 percent in preventing COVID-19. (Credit Image: © David Talukdar/ZUMA Wire)、クレジット：©Ｄａｖｉｄ Ｔａｌｕｋｄａｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021031109385
2021年03月06日Coronavirus Vaccination in Indiaキーワード：新型コロナウイルス、ワクチン、バーラト・バイオテック、インド、実物、バイアル、容器、瓶－March 6, 2021, Barpeta, Assam, India: A health worker prepares a dose of COVID-19 vaccine (Bharat Biotech COVAXIN) at a government hospital on March 6, 2021 in Barpeta, India. India has entered the second phase of its vaccination drive with two ‘Made in India vaccines- Covishield and Covaxin. The Indian Council of Medical Research and Bharat Biotech announced that phase 3 results of Covaxin have shown an interim vaccine efficacy of 81 percent in preventing COVID-19. (Credit Image: © David Talukdar/ZUMA Wire)、クレジット：©Ｄａｖｉｄ Ｔａｌｕｋｄａｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021031109386
2021年03月06日Coronavirus Vaccination in Indiaキーワード：新型コロナウイルス、ワクチン、バーラト・バイオテック、インド、実物、バイアル、容器、瓶－March 6, 2021, Barpeta, Assam, India: A health worker prepares a dose of COVID-19 vaccine (Bharat Biotech COVAXIN) at a government hospital on March 6, 2021 in Barpeta, India. India has entered the second phase of its vaccination drive with two ‘Made in India vaccines- Covishield and Covaxin. The Indian Council of Medical Research and Bharat Biotech announced that phase 3 results of Covaxin have shown an interim vaccine efficacy of 81 percent in preventing COVID-19. (Credit Image: © David Talukdar/ZUMA Wire)、クレジット：©Ｄａｖｉｄ Ｔａｌｕｋｄａｒ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021031109390
02:03.002021年07月21日Two-thirds of Indians above 6 years have COVID-19 antibodies: health research bodySTORY: Two-thirds of Indians above 6 years have COVID-19 antibodies: health research bodyDATELINE: July 21, 2021LENGTH: 00:02:03LOCATION: New DelhiCATEGORY: HEALTHSHOTLIST:1. various of the India gate and the government building2. various of people wearing masks3. various of AIIMS hospital area4. various of vaccination center5. various of trafficSTORYLINE:The latest survey conducted by India‘s top health research body, Indian Council of Medical Research (ICMR), has found two-thirds of the country‘s general population above the age of six years have antibodies against COVID-19 but one in three are still vulnerable, officials said Tuesday.The fourth serosurvey was conducted to determine the scale of COVID-19 antibodies in the people.The survey showed 67.6 percent people above six years have antibodies against the COVID-19.The results, however, mean around 400 million pe.....、クレジット：新華社／共同通信イメージズ
商品コード: 2021081804486
02:00.802021年09月29日India‘s top health research body says schools need to be opened in phased mannerSTORY: India‘s top health research body says schools need to be opened in phased mannerDATELINE: Sept. 29, 2021LENGTH: 00:02:01LOCATION: New DelhiCATEGORY: HEALTH/EDUCATIONSHOTLIST:1. various of India gate2. various of schools3. various of students4. various of trafficSTORYLINE:India‘s top health research body, the Indian Council of Medical Research, has suggested in a study that schools in the country need to be reopened in a phased manner. According to the latest study, schools should be allowed to remain open and safe with the appropriate implementation of multi-layered mitigation measures where children‘s participation remains essential. An opinion piece published in the Indian Journal of Medical Research, “Reopening of schools during COVID-19 pandemic: A persistent dilemma,“ said evidence indicates that going back to the education system to what it was in pre-.....、クレジット：新華社／共同通信イメージズ
商品コード: 2021093012676
01:36.022021年12月13日India designs kit to detect Omicron variant in 2 hoursSTORY: India designs kit to detect Omicron variant in 2 hoursDATELINE: Dec. 13, 2021LENGTH: 00:01:36LOCATION: New DelhiCATEGORY: HEALTHSHOTLIST:1. Shot of India gate2. Shots of people wearing masks3. Shots of COVID-19 testing4. Shots of hospital area5. Shots of trafficSTORYLINE:The Indian Council of Medical Research has designed a testing kit that can detect the Omicron variant (B.1.1.529) of the coronavirus in just two hours, local media reported on Sunday. The testing kit was developed by a team of scientists of the regional medical research centre for the northeast region. “This is important because as of now a minimum of 36 hours is required for targeted sequencing and four to five days for whole-genome sequencing to detect the variant,“ lead scientist Dr. Biswajyoti Borkakoty was quoted as saying. Internal validation has shown that the tests are “100 perc.....、クレジット：新華社／共同通信イメージズ
商品コード: 2021121408137
2022年01月17日Coviself Test kit in Kolkata, India - 17 Jan 2022January 17, 2022, Kolkata, West Bengal, India: A Coviself Test kit is seen displayed along with a Vaccine injection and some Paracetamol Tablets..CoviSelf is India‘s first ICMR (Indian council of Medical Research) approved COVID19 Rapid Antigen Self test kit by Mylab prescribed by Government of India for making Rapid Covid Test (Credit Image: © Avishek Das/SOPA Images via ZUMA Press Wire)、クレジット：©Ａｖｉｓｈｅｋ Ｄａｓ／ＳＯＰＡ Ｉｍａｇｅｓ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2022011813389
2022年01月17日Coviself Test kit in Kolkata, India - 17 Jan 2022January 17, 2022, Kolkata, West Bengal, India: In this photo illustration a Coviself Rapid Antigen Test Kit Package is seen with Covid19 symbols on background..CoviSelf is India‘s first ICMR (Indian council of Medical Research) approved COVID19 Rapid Antigen Self test kit by Mylab prescribed by Government of India for making Rapid Covid Test (Credit Image: © Avishek Das/SOPA Images via ZUMA Press Wire)、クレジット：©Ａｖｉｓｈｅｋ Ｄａｓ／ＳＯＰＡ Ｉｍａｇｅｓ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2022011813040
2022年01月17日Coviself Test kit in Kolkata, India - 17 Jan 2022January 17, 2022, Kolkata, West Bengal, India: In this photo illustration a blank Coviself Rapid Antigen Test Kit is seen with a Covid-19 Test Vial and Covid19 symbols on background..CoviSelf is India‘s first ICMR (Indian council of Medical Research) approved COVID19 Rapid Antigen Self test kit by Mylab prescribed by Government of India for making Rapid Covid Test (Credit Image: © Avishek Das/SOPA Images via ZUMA Press Wire)、クレジット：©Ａｖｉｓｈｅｋ Ｄａｓ／ＳＯＰＡ Ｉｍａｇｅｓ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2022011813072
2022年01月17日Coviself Test kit in Kolkata, India - 17 Jan 2022January 17, 2022, Kolkata, West Bengal, India: In this photo illustration a Coviself Rapid Antigen Test Kit along with a vaccine injection and a Test vial are seen on a background of Covid19 symbols..CoviSelf is India‘s first ICMR (Indian council of Medical Research) approved COVID19 Rapid Antigen Self test kit by Mylab prescribed by Government of India for making Rapid Covid Test (Credit Image: © Avishek Das/SOPA Images via ZUMA Press Wire)、クレジット：©Ａｖｉｓｈｅｋ Ｄａｓ／ＳＯＰＡ Ｉｍａｇｅｓ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2022011812757
2022年01月17日Coviself Test kit in Kolkata, India - 17 Jan 2022January 17, 2022, Kolkata, West Bengal, India: A woman seen doing a self swab collection through a Mylab CoviSelf Antigen Test kit..CoviSelf is India‘s first ICMR (Indian council of Medical Research) approved COVID19 Rapid Antigen Self test kit by Mylab prescribed by Government of India for making Rapid Covid Test (Credit Image: © Avishek Das/SOPA Images via ZUMA Press Wire)、クレジット：©Ａｖｉｓｈｅｋ Ｄａｓ／ＳＯＰＡ Ｉｍａｇｅｓ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2022011812592
2022年01月17日Coviself Test kit in Kolkata, India - 17 Jan 2022January 17, 2022, Kolkata, West Bengal, India: In this photo illustration a swab sample seen put into a Rapid Antigen Test Kit for the Covid-19 test..CoviSelf is India‘s first ICMR (Indian council of Medical Research) approved COVID19 Rapid Antigen Self test kit by Mylab prescribed by Government of India for making Rapid Covid Test (Credit Image: © Avishek Das/SOPA Images via ZUMA Press Wire)、クレジット：©Ａｖｉｓｈｅｋ Ｄａｓ／ＳＯＰＡ Ｉｍａｇｅｓ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2022011812591
2022年01月17日Coviself Test kit in Kolkata, India - 17 Jan 2022January 17, 2022, Kolkata, West Bengal, India: In this photo illustration a Coviself Rapid Antigen Test Kit with negative results next to a vaccine injection..CoviSelf is India‘s first ICMR (Indian council of Medical Research) approved COVID19 Rapid Antigen Self test kit by Mylab prescribed by Government of India for making Rapid Covid Test (Credit Image: © Avishek Das/SOPA Images via ZUMA Press Wire)、クレジット：©Ａｖｉｓｈｅｋ Ｄａｓ／ＳＯＰＡ Ｉｍａｇｅｓ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2022011812544
2022年01月17日Coviself Test kit in Kolkata, India - 17 Jan 2022January 17, 2022, Kolkata, West Bengal, India: A woman holds a Coviself Test kit having Negative results after doing a Rapid Antigen Test at home..CoviSelf is India‘s first ICMR (Indian council of Medical Research) approved COVID19 Rapid Antigen Self test kit by Mylab prescribed by Government of India for making Rapid Covid Test (Credit Image: © Avishek Das/SOPA Images via ZUMA Press Wire)、クレジット：©Ａｖｉｓｈｅｋ Ｄａｓ／ＳＯＰＡ Ｉｍａｇｅｓ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2022011812667
2022年01月17日Coviself Test kit in Kolkata, India - 17 Jan 2022January 17, 2022, Kolkata, West Bengal, India: In this Photo illustration a Coviself Rapid Antigen Test Kit is seen with negative results and a Covid19 virus symbol on background..CoviSelf is India‘s first ICMR (Indian council of Medical Research) approved COVID19 Rapid Antigen Self test kit by Mylab prescribed by Government of India for making Rapid Covid Test (Credit Image: © Avishek Das/SOPA Images via ZUMA Press Wire)、クレジット：©Ａｖｉｓｈｅｋ Ｄａｓ／ＳＯＰＡ Ｉｍａｇｅｓ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2022011812284
2022年01月17日Coviself Test kit in Kolkata, India - 17 Jan 2022January 17, 2022, Kolkata, West Bengal, India: In this photo illustration a Coviself Rapid Antigen Test kit with Negative Result seen with some Covid19 words in the background..CoviSelf is India‘s first ICMR (Indian council of Medical Research) approved COVID19 Rapid Antigen Self test kit by Mylab prescribed by Government of India for making Rapid Covid Test (Credit Image: © Avishek Das/SOPA Images via ZUMA Press Wire)、クレジット：©Ａｖｉｓｈｅｋ Ｄａｓ／ＳＯＰＡ Ｉｍａｇｅｓ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2022011812618
02:01.442022年01月19日Indian gov‘t asks states to ramp up COVID-19 testing amid surging infectionsSTORY: Indian gov‘t asks states to ramp up COVID-19 testing amid surging infectionsDATELINE: Jan. 19, 2022LENGTH: 0:02:01LOCATION: New DelhiCATEGORY: HEALTHSHOTLIST:1 various of the India gate2 various of people wearing masks in the streets3 various of a COVID-19 testing center4 various of ambulance and trafficSTORYLINE:India‘s federal health ministry urged all states to ramp up the process of COVID-19 testing amid a surge in new cases.“Testing remains a key and crucial component of the framework. However, it is seen from the data available on the Indian Council of Medical Research portal that testing has declined in many states,“ said a directive from the ministry.“All those who are symptomatic must be tested. All at-risk contacts of laboratory confirmed cases must also be tested,“ it added.India is currently battling the third wave of the ongoing COVID-19 pandemic......、クレジット：新華社／共同通信イメージズ
商品コード: 2022012008252
01:48.962022年03月04日Health agency chief says unvaccinated people account for 92 pct COVID-19 deaths this year in IndiaSTORY: Health agency chief says unvaccinated people account for 92 pct COVID-19 deaths this year in IndiaDATELINE: March 4, 2022LENGTH: 00:01:49LOCATION: New DelhiCATEGORY: HEALTHSHOTLIST:1. various of the street view of IndiaSTORYLINE:Chief of the Indian Council of Medical Research (ICMR) Balram Bhargava said on Thursday that unvaccinated people account for 92 percent of COVID-19 deaths so far this year in India. “During 2022, unvaccinated individuals were 92 percent responsible for all the deaths,“ he told a press briefing. Quoting a study on the effectiveness of COVID-19 vaccines in preventing mortality, Bhargava said the first dose of COVID-19 vaccine is 98.9 percent effective and if both doses are given, the effectiveness is 99.3 percent. V.K...＝ 配信日： ２０２２（令和４）年３月４日、クレジット：新華社／共同通信イメージズ
商品コード: 2022030813849
- 1
